France – Produits pharmaceutiques – Marché UNICANCER de la fourniture et de la livraison de médicaments 26-28 - Relance deuxième vague

DeadlineJune 8, 2026 at 12:00 PMClosed 37 days ago

AI summary

This tender concerns the supply and delivery of pharmaceutical products for UNICANCER, a French oncology network. The contract covers a three-year period (2026-2028) and represents a relaunch of the second wave of procurement for medicines required by cancer treatment centres.

#pharmaceutical supply#oncology medicines#france#medical distribution#healthcare procurement#cancer treatment
Fit for

Pharmaceutical suppliers and wholesalers with authorization to distribute medicines in France and proven experience in oncology product supply should apply.

Key requirements

Suppliers must be authorized pharmaceutical distributors capable of supplying a broad range of oncology medications. They must demonstrate logistics capacity for reliable delivery across France and comply with pharmaceutical regulatory standards.

Frequently asked questions

  • What is this tender about?

    This tender concerns the supply and delivery of pharmaceutical products for UNICANCER, a French oncology network. The contract covers a three-year period (2026-2028) and represents a relaunch of the second wave of procurement for medicines required by cancer treatment centres.

  • What are the requirements for suppliers?

    Suppliers must be authorized pharmaceutical distributors capable of supplying a broad range of oncology medications. They must demonstrate logistics capacity for reliable delivery across France and comply with pharmaceutical regulatory standards.

  • What type of company should bid?

    Pharmaceutical suppliers and wholesalers with authorization to distribute medicines in France and proven experience in oncology product supply should apply.

  • Who is the buyer?

    The buyer is UNICANCER ACHATS.

  • When does this tender close?

    Submissions close on June 8, 2026.

Marché UNICANCER de la fourniture et de la livraison de médicaments 26-28 - Relance deuxième vague

Buyer
UNICANCER ACHATS
Buyer ID: 49118605200024
101 rue de Tolbiac, 75013, PARIS
Body responsible for review procedures
Tribunal judiciaire de Paris
Buyer ID: 17750111101763
75000, Paris
Other organization
DEMATIS
Buyer ID: 45072478600030
75015, Paris

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…